AU2001282938A1 - Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by vla-4 - Google Patents
Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by vla-4Info
- Publication number
- AU2001282938A1 AU2001282938A1 AU2001282938A AU8293801A AU2001282938A1 AU 2001282938 A1 AU2001282938 A1 AU 2001282938A1 AU 2001282938 A AU2001282938 A AU 2001282938A AU 8293801 A AU8293801 A AU 8293801A AU 2001282938 A1 AU2001282938 A1 AU 2001282938A1
- Authority
- AU
- Australia
- Prior art keywords
- vla
- inhibitors
- amino acid
- acid derivatives
- alpha amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22013200P | 2000-07-21 | 2000-07-21 | |
US60220132 | 2000-07-21 | ||
PCT/US2001/023075 WO2002008202A2 (en) | 2000-07-21 | 2001-07-20 | Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by vla-4 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001282938A1 true AU2001282938A1 (en) | 2002-02-05 |
Family
ID=22822201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001282938A Abandoned AU2001282938A1 (en) | 2000-07-21 | 2001-07-20 | Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by vla-4 |
Country Status (3)
Country | Link |
---|---|
US (2) | US6803370B2 (en) |
AU (1) | AU2001282938A1 (en) |
WO (1) | WO2002008202A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6960597B2 (en) | 2000-06-30 | 2005-11-01 | Orth-Mcneil Pharmaceutical, Inc. | Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists |
US6803370B2 (en) * | 2000-07-21 | 2004-10-12 | Elan Pharmaceuticals, Inc. | Alpha amino acid derivatives—inhibitors of leukocyte adhesion mediated by VLA-4 |
DE10106699C2 (en) * | 2001-02-14 | 2003-11-27 | Leica Microsystems | Touch sensor and device for protecting a protruding component |
JP4617449B2 (en) | 2002-07-11 | 2011-01-26 | ヴィキュロン ファーマシューティカルズ インコーポレイテッド | N-hydroxyamide derivative having antibacterial activity |
AR050425A1 (en) | 2004-07-08 | 2006-10-25 | Elan Pharm Inc | MULTIVALENT ANTAGONISTS OF VLA-4 THAT INCLUDES POLYMERIC FRACTIONS. PHARMACEUTICAL COMPOSITIONS |
JP2006121798A (en) * | 2004-10-20 | 2006-05-11 | Ishikawajima Harima Heavy Ind Co Ltd | Motor driving device |
CA2608073C (en) * | 2005-05-20 | 2013-08-06 | Elan Pharmaceuticals, Inc. | Imidazolone phenylalanine derivatives |
WO2011020874A1 (en) | 2009-08-20 | 2011-02-24 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy |
US20160002159A1 (en) * | 2013-02-13 | 2016-01-07 | Neal ZONDLO | Perfluoro-tert-butyl hydroxyproline |
CN108929314B (en) * | 2017-05-27 | 2021-02-12 | 首都医科大学 | 3R-indolylmethyl-6S-acidic amino acid modified piperazine-2, 5-dione, and synthesis, activity and application thereof |
EP4284947A1 (en) | 2021-01-29 | 2023-12-06 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods of assessing the risk of developing progressive multifocal leukoencephalopathy in patients treated with vla-4 antagonists |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0330506A3 (en) | 1988-02-26 | 1990-06-20 | Dana Farber Cancer Institute | Vla proteins |
US5510332A (en) | 1994-07-07 | 1996-04-23 | Texas Biotechnology Corporation | Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor |
JPH10506608A (en) | 1994-07-11 | 1998-06-30 | アセナ ニューロサイエンシーズ,インコーポレイテッド | Inhibitor of leukocyte adhesion |
US6329372B1 (en) * | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
EP1073637B1 (en) * | 1998-04-27 | 2006-08-02 | Centre National De La Recherche Scientifique | 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases |
GB9821061D0 (en) * | 1998-09-28 | 1998-11-18 | Celltech Therapeutics Ltd | Chemical compounds |
WO2000043372A1 (en) | 1999-01-22 | 2000-07-27 | Elan Pharmaceuticals, Inc. | Acyl derivatives which treat vla-4 related disorders |
US6803370B2 (en) * | 2000-07-21 | 2004-10-12 | Elan Pharmaceuticals, Inc. | Alpha amino acid derivatives—inhibitors of leukocyte adhesion mediated by VLA-4 |
-
2001
- 2001-07-20 US US09/910,702 patent/US6803370B2/en not_active Expired - Fee Related
- 2001-07-20 WO PCT/US2001/023075 patent/WO2002008202A2/en active Application Filing
- 2001-07-20 AU AU2001282938A patent/AU2001282938A1/en not_active Abandoned
-
2004
- 2004-09-07 US US10/936,070 patent/US7745454B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7745454B2 (en) | 2010-06-29 |
US20020052470A1 (en) | 2002-05-02 |
WO2002008202A2 (en) | 2002-01-31 |
US6803370B2 (en) | 2004-10-12 |
WO2002008202A3 (en) | 2002-04-25 |
US20050085459A1 (en) | 2005-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2623900A (en) | Compounds which inhibit leukocyte adhesion mediated by vla-4 | |
HUP0002495A3 (en) | Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4, pharmaceutical compositions comprising thereof and their use | |
HUP0003921A3 (en) | Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4, pharmaceutical compositions comprising thereof and their use | |
HK1045157A1 (en) | Compounds which inhibit leukocyte adhesion mediated by vla-4 | |
HUP0004529A3 (en) | Sulfonilated dipeptide-compounds which inhibit leukocyte adhesion mediated by vla-4, pharmaceutical compositions comprising thereof and their use | |
AU2001263181A1 (en) | Refastenable bonding of garment side panels | |
AU2003265235A1 (en) | Non-affinity purification of proteins | |
HUP0002682A3 (en) | Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 | |
AU2003223188A1 (en) | Adhesives | |
AU2003256329A1 (en) | Use of adhesion molecules as bond stress-enhanced nanoscale binding switches | |
AU2001277960A1 (en) | 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by vla-4 | |
AU2003294056A1 (en) | Polyamino acids functionalized by at least one (oligo)amino acid group and therapeutic uses | |
AU2001276022A1 (en) | Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by vla-4 | |
AU3348800A (en) | Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 | |
AU2001282938A1 (en) | Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by vla-4 | |
AU2001268701A1 (en) | Methods of enhancing adhesion | |
AU2623800A (en) | Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 | |
AU4810600A (en) | Method of inhibiting leukocyte adhesion to fibrinogen | |
AU2003219580A1 (en) | Novel therapeutical use of byakangelicin | |
EP1542718A4 (en) | Peptide derivative fusion inhibitors of hiv infection | |
EP1369479A4 (en) | Novel cell adhesion molecule specific to activated leukocyte | |
AU3348700A (en) | Compounds which inhibit leukocyte adhesion mediated by vla-4 | |
AU2003282162A1 (en) | Novel adhesives comprising diacetals | |
AU2003217174A1 (en) | Novel variants of rankl protein | |
AU2003280382A1 (en) | Enzymatic polymerisation of miniemulsions |